Chemoinformaics analysis of 2,5-Dimethyl-3-pentylpyrazine
| Molecular Weight | 178.279 | nRot | 4 |
| Heavy Atom Molecular Weight | 160.135 | nRig | 12 |
| Exact Molecular Weight | 178.147 | nRing | 1 |
| Solubility: LogS | -2.201 | nHRing | 1 |
| Solubility: LogP | 1.456 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 32.5723 |
| nHD | 0 | BPOL | 20.3377 |
| QED | 0.828 |
| Synth | 2.179 |
| Natural Product Likeliness | 0.193 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.006 |
| HIA | 0.006 |
| CACO-2 | -4.683 |
| MDCK | 0.0000327 |
| BBB | 0.988 |
| PPB | 0.602401 |
| VDSS | 1.265 |
| FU | 0.272441 |
| CYP1A2-inh | 0.695 |
| CYP1A2-sub | 0.979 |
| CYP2c19-inh | 0.357 |
| CYP2c19-sub | 0.906 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.844 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.857 |
| CYP3a4-inh | 0.093 |
| CYP3a4-sub | 0.599 |
| CL | 6.178 |
| T12 | 0.524 |
| hERG | 0.039 |
| Ames | 0.514 |
| ROA | 0.744 |
| SkinSen | 0.197 |
| Carcinogencity | 0.125 |
| EI | 0.268 |
| Respiratory | 0.657 |
| NR-Aromatase | 0.489 |
| Antiviral | No |
| Prediction | 0.707891 |